logo

Health News

Share
ecigeratte oct18At a time, when e-cigarettes have been getting a lot of bad press, a new study has found a positive association between the number of people using e-cigarettes and the success rate of giving up smoking. The study led by Dr. Emma Beard, UCL Division of Psychology and Language Sciences, showed that...
Read More

Canadian cannabis healthcare technology company Cannalogue said it has submitted an application to Health Canada to conduct a clinical trial with medical cannabis for COVID-19, the disease caused by the novel coronavirus. Toronto-based Cannalogue added that if approved by Health Canada, it will enroll...
Read More
elmiron oct14

Interstitial Cystitis Drug Linked To Retinal Damage: Study



Elmiron, the only FDA-approved oral drug to treat interstitial cystitis, also known as bladder pain syndrome, has been found to be associated with a vision-threatening eye condition, according to a new study.
Read More
pigs april18

No Piggy Tale: Some Brain Functions Restored Even Hours After Death



The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
bornbaby sept30A recent study, done by researchers from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators, found that there is a difference in the gut bacteria of babies delivered vaginally and those born via caesarean.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
06/26/20HRTXHTX-011 (Resubmitted NDA)FDA decision on HTX-011 for the management of postoperative pain
06/26/20ICPTObeticholic acid (NDA)FDA decision on obeticholic acid for fibrosis due to nonalcoholic steatohepatitis
06/25/20ZGNXFINTEPLA (NDA)FDA decision on FINTEPLA for the treatment of seizures associated with Dravet syndrome
06/23/20TKPHF.PK, TAKALUNBRIG (NDA)FDA decision on ALUNBRIG as first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) metastatic NSCLC
06/19/20GSK.L, GSKBelantamab mafodotin (BLA)FDA decision on Belantamab mafodotin for the treatment of patients with relapsed or refractory multiple myeloma
06/19/20EVOKGimotI (NDA resubmission)FDA decision on Gimoti for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis.
View All




>